Kousaku Mimura

2.9k total citations
49 papers, 2.3k citations indexed

About

Kousaku Mimura is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kousaku Mimura has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Immunology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kousaku Mimura's work include Immune Cell Function and Interaction (21 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immunotherapy and Immune Responses (14 papers). Kousaku Mimura is often cited by papers focused on Immune Cell Function and Interaction (21 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immunotherapy and Immune Responses (14 papers). Kousaku Mimura collaborates with scholars based in Japan, Singapore and Sweden. Kousaku Mimura's co-authors include Koji Kono, Hideki Fujii, Yoshihiko Kawaguchi, Mitsuaki Watanabe, Takanori Maruyama, Hideki Fujii, Yoshiyuki Suzuki, Dario Campana, Noriko Shimasaki and Shinichirou Izawa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Kousaku Mimura

48 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kousaku Mimura Japan 25 1.5k 1.3k 542 347 295 49 2.3k
Lucas Ferrari de Andrade United States 16 1.6k 1.0× 1.6k 1.2× 666 1.2× 328 0.9× 118 0.4× 29 2.6k
Tomonori Yaguchi Japan 28 989 0.7× 912 0.7× 687 1.3× 281 0.8× 115 0.4× 70 2.0k
Audrey Lupo France 20 1.7k 1.1× 1.5k 1.1× 597 1.1× 693 2.0× 101 0.3× 44 2.8k
Els M.E. Verdegaal Netherlands 24 1.6k 1.1× 1.6k 1.2× 1.1k 2.1× 213 0.6× 156 0.5× 62 3.1k
Richard D. Huhn United States 16 1.5k 1.0× 1.6k 1.3× 535 1.0× 121 0.3× 208 0.7× 41 2.6k
Yuping Sun China 27 1.3k 0.9× 831 0.6× 818 1.5× 502 1.4× 100 0.3× 87 2.4k
Roberta Zappasodi United States 24 1.5k 1.0× 1.6k 1.3× 877 1.6× 317 0.9× 120 0.4× 56 2.9k
Daniel Sanghoon Shin United States 19 1.7k 1.1× 1.3k 1.0× 971 1.8× 324 0.9× 68 0.2× 35 2.8k
Robert Yuan United States 8 1.0k 0.7× 794 0.6× 666 1.2× 376 1.1× 70 0.2× 10 1.9k
Laurence Buisseret Belgium 21 2.6k 1.7× 1.6k 1.3× 684 1.3× 657 1.9× 181 0.6× 65 3.6k

Countries citing papers authored by Kousaku Mimura

Since Specialization
Citations

This map shows the geographic impact of Kousaku Mimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kousaku Mimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kousaku Mimura more than expected).

Fields of papers citing papers by Kousaku Mimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kousaku Mimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kousaku Mimura. The network helps show where Kousaku Mimura may publish in the future.

Co-authorship network of co-authors of Kousaku Mimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kousaku Mimura. A scholar is included among the top collaborators of Kousaku Mimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kousaku Mimura. Kousaku Mimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibata, Masahiko, Takahiro Nakajima, Takashi Yazawa, et al.. (2022). Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more. Oncotarget. 13(1). 1273–1285. 9 indexed citations
2.
Sundar, Raghav, Sun Young Rha, Hiroki Yamaue, et al.. (2018). A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer. BMC Cancer. 18(1). 332–332. 33 indexed citations
3.
Ashizawa, Mai, Hirokazu Okayama, Teruhide Ishigame, Kousaku Mimura, & Koji Kono. (2018). Identification of microRNAs that target PD-L1 in mismatch repair-deficient colorectal cancer.. Journal of Clinical Oncology. 36(5_suppl). 85–85. 2 indexed citations
4.
Mimura, Kousaku, Jun Liang Teh, Hirokazu Okayama, et al.. (2017). PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer. Cancer Science. 109(1). 43–53. 259 indexed citations
5.
Chang, Yu-Hsiang, John G. Connolly, Noriko Shimasaki, et al.. (2013). A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells. Cancer Research. 73(6). 1777–1786. 272 indexed citations
6.
Mimura, Kousaku, Kensuke Shiraishi, Anja Müeller, et al.. (2013). The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer. The Journal of Immunology. 191(12). 6261–6272. 74 indexed citations
7.
Suzuki, Yoshiyuki, Kousaku Mimura, Yuya Yoshimoto, et al.. (2012). Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma. Cancer Research. 72(16). 3967–3976. 185 indexed citations
8.
Okita, Riki, Dimitrios Mougiakakos, Takashi Ando, et al.. (2012). HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines. The Journal of Immunology. 188(5). 2136–2145. 50 indexed citations
9.
Kono, Koji & Kousaku Mimura. (2012). Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting. OncoImmunology. 2(1). e22197–e22197. 16 indexed citations
10.
Izawa, Shinichirou, Koji Kono, Kousaku Mimura, et al.. (2011). H2O2 production within tumor microenvironment inversely correlated with infiltration of CD56dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. Cancer Immunology Immunotherapy. 60(12). 1801–1810. 72 indexed citations
11.
Mimura, Kousaku, Shinichiro Izawa, Takanori Maruyama, et al.. (2011). [The effect of immune-based therapy with cytotoxic T lymphocyte and molecular targeting therapy for HER2 in esophageal squamous cell carcinoma].. PubMed. 38(12). 1918–20. 2 indexed citations
12.
Mimura, Kousaku, Takashi Ando, Isabel Poschke, et al.. (2010). T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2. International Journal of Cancer. 128(2). 390–401. 48 indexed citations
13.
Kawaguchi, Yoshihiko, Koji Kono, Yoshiki Mizukami, Kousaku Mimura, & Hideki Fujii. (2009). Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma: relation to susceptibility to perforin-granzyme.. PubMed. 29(6). 2137–46. 15 indexed citations
14.
Ando, Takashi, Kousaku Mimura, C. Christian Johansson, et al.. (2008). Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress. The Journal of Immunology. 181(12). 8382–8390. 86 indexed citations
15.
Akaike, Hidenori, Koji Kono, Hidemitsu Sugai, et al.. (2007). Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer.. PubMed. 27(1A). 449–57. 52 indexed citations
16.
Mimura, Kousaku, Koji Kono, Scott Southwood, et al.. (2006). Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs. Cancer Immunology Immunotherapy. 55(11). 1358–1366. 6 indexed citations
17.
Kawaguchi, Yoshihiko, Koji Kono, Kousaku Mimura, et al.. (2006). Cetuximab induce antibody‐dependent cellular cytotoxicity against EGFR‐expressing esophageal squamous cell carcinoma. International Journal of Cancer. 120(4). 781–787. 142 indexed citations
18.
19.
Mimura, Kousaku, Koji Kono, Mitsuhiko Hanawa, et al.. (2005). Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity against Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 11(13). 4898–4904. 77 indexed citations
20.
Kono, Koji, Eiji Sato, Hirofumi Naganuma, et al.. (2004). Trastuzumab (Herceptin) Enhances Class I-Restricted Antigen Presentation Recognized by HER-2/neu-Specific T Cytotoxic Lymphocytes. Clinical Cancer Research. 10(7). 2538–2544. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucas Ferrari de Andrade Breakdown of academic impact, for papers by Tomonori Yaguchi Breakdown of academic impact, for papers by Audrey Lupo Breakdown of academic impact, for papers by Els M.E. Verdegaal Breakdown of academic impact, for papers by Richard D. Huhn Breakdown of academic impact, for papers by Yuping Sun Breakdown of academic impact, for papers by Roberta Zappasodi Breakdown of academic impact, for papers by Daniel Sanghoon Shin Breakdown of academic impact, for papers by Robert Yuan Breakdown of academic impact, for papers by Laurence Buisseret
Rankless by CCL
2026